Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

QUANTUM CORP /DE/ (QMCO)

  • Business News
  • June 02, 2026, 12:20 UTC
  • 2
  • 1 comments

Quantum Announces Preliminary Fiscal Fourth Quarter 2026 Financial Results

Market reaction Comment Full text

STRATASYS LTD. (SSYS)

  • Business News
  • June 02, 2026, 12:15 UTC
  • 3
  • 1 comments

Stratasys Celebrates Grand Opening of Americas Headquarters in Minnesota

Market reaction Comment Full text

MORGAN STANLEY (MS)

  • Business News
  • June 02, 2026, 12:15 UTC
  • 2
  • 1 comments

Morgan Stanley Expansion Capital Leads $33 Million Growth Financing For Subtle Medical

Market reaction Comment Full text

LANTERN PHARMA INC. (LTRN)

  • Business News
  • June 02, 2026, 12:13 UTC
  • 3
  • 1 comments

Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment Duration in EGFR Exon 21 L858R Lung Cancer

Market reaction Comment Full text

HERON THERAPEUTICS, INC. /DE/ (HRTX)

  • Business News
  • June 02, 2026, 12:12 UTC
  • 3
  • 1 comments

U.S. District Court Issues Decision Regarding CINVANTI® Patents

Market reaction Comment Full text

GAXOS.AI INC. (GXAI)

  • Business News
  • June 02, 2026, 12:12 UTC
  • 5
  • 1 comments

Gaxos Secures Additional Funding from Amazon AWS to Accelerate AI Sales Platform Development

Market reaction Comment Full text

ZEBRA TECHNOLOGIES CORP (ZBRA)

  • Business News
  • June 02, 2026, 12:10 UTC
  • 5
  • 1 comments

Zebra Technologies Empowers Frontline Workers with New DNA Software Platforms and AI-Powered Solutions

Market reaction Comment Full text

KARMAN HOLDINGS INC. (KRMN)

  • Business News
  • June 02, 2026, 12:10 UTC
  • 5
  • 1 comments

Stefan Knighton Joins Karman Space & Defense as Company’s First Chief Information and Artificial Intelligence Officer

Market reaction Comment Full text

AstraZeneca (AZN)

  • Business News
  • June 02, 2026, 12:07 UTC
  • 5
  • 1 comments

Camizestrant combination delayed time to first progression in patients with advanced HR-positive breast cancer with an ESR1 tumour mutation

Market reaction Comment Full text

INmune Bio Inc. (INMB)

  • Business News
  • June 02, 2026, 12:07 UTC
  • 5
  • 1 comments

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarke

Market reaction Comment Full text
  • Previous
  • 1065
  • 1066
  • 1067
  • 1068
  • 1069
  • Next

Search

News categories

  • Technical Exchange News(13335)
  • Event(6229)
  • SEC News(339323)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(188301)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin